Clinical significance of basal core promoter and precore mutations in chronic hepatitis B

Hepato-Gastroenterology

Volumn 54, Issue 80, 2007, Pages 2319-2323

  Ozgenc, Onur ^a,d   Ozacar, T ^b   Erensoy, S ^b   Inan, N ^a   Ari, A ^a   Kuruuzum, Z ^c   Bilgic, A ^b  

^a Izmir Teaching and Research Hospital   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

^d Izmir Ataturk Training and Research Hospital   (Turkey)

Author keywords

Basal core promoter; Chronic hepatitis B; Mutants; Precore

Indexed keywords

ALPHA INTERFERON; LAMIVUDINE;

ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MONOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; TREATMENT RESPONSE;

CODON, TERMINATOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION, VIRAL; GENOTYPE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MUTATION; PROMOTER REGIONS (GENETICS); TURKEY; VIRAL CORE PROTEINS; VIRAL LOAD;

EID: 37749009412     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Cho SW, Hahm K-B, Kim JH: Reversion from precore/core promoter mutants to wild-type hepatitis B virus during the course of lamivudine therapy. Hepatology 2000; 32:1163-1169.
2. Hadziyannis SJ, Vassilopoulos D: Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection. Antiviral Res 2001; 52:91-98.
3. Keeffe EB, Dieterich DT, Han S-HB, Jacobson IM, Martin P, Schiff ER, Tobias H, Wright TL: A treatment algorithm for the management of chronic hepatitis B infection in the United States. Clin Gastroenterol Hepatol 2004; 2:87-106.
4. Tatulli I, Francavilla R, Rizzo GL, Vinciguerra V, Lerardi E, Amaruso A, Panella C, Francavilla A: Lamivudine and alpha-interferon in combination long term for precore mutant chronic hepatitis B. J Hepatol 2001; 35:805-810.
5. Yuen M-F, Sablon E, Tanaka Y, Kato T, Mizokami M, Doutreloigne J, Yuan H-J, Wong DK-H, Sum S-M, Lai C-L: Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong. J Hepatol 2004; 41:119-125.
6. Chu C-J, Keeffe EB, Han S-H, Perrillo RP, Min Ad, Soldevilla-Pico C, Carey W, Brown RS, Luketic VA, Terrault N, Lok ASF, and The U.S. HBV Epidemiology Study Group: Prevalence of HBV precore/core promoter variants in the United States. Hepatology 2003; 38:619-628.
7. Buckwold VE, Xu Z, Chen M, Yen TSB, Ou J-H: Effects of a naturally occuring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J Virol 1996; 70:5845-5851.
8. Hunt CM, McGill JM, Allen MI, Condreay LD: Clinical relevance of hepatitis B viral mutations. Hepatology 2000; 31:1037-1044.
9. Kramvis A, Kew MC: The core promoter of hepatitis B virus. J Viral Hepat 1999; 6:415-427.
10. Chan HLY, Hussain M, Lok ASF: Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology 1999; 29(3):976-984.
11. Mbayed VA, Lopez JL, Telenta PFS, Palacios G, Badia I, Ferro A, Galoppo C, Campos R: Distribution of hepatitis B virus genotypes in two different pediatric populations from Argentina. J Clin Microbiol 1998; 36 (11):3362-3365.
12. Lindh M, Andersson A-S, Gusdal A: Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 1997; 175:1285-1293.
13. Tassapoulos NC, Volpes R, Pastore G, Heathcote J, Buti M, Goldin RD, Hawley S, Barber J, Condreay L, Gray DF, and The Lamivudine Precore Mutant Study Group: Hepatology 1999; 29.889-896.
14. Gandhe SS, Chadha MS, Walimbe AM, Arankalle VA: Hepatitis B virus: prevalence of precore/core promoter mutants in different clinical categories of Indian patients. J Viral Hepat 2003; 10:367-382.
15. Yuen M-F, Sablon E, Yuan H-J, Hui C-K, Wong DK-H, Doutreloigne J, Wong BJ-Y, Chan AO-O, Lai C-L: Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus. J Infect Dis 2002; 186:1335-1338.
16. Papatheodoridis GV, Manesis E, Hadziyannis SJ: The long-term outcome of interferon-alpha treated and untreated patients with HBeAg-negative chronic hepatitis B. J Hepatol 2001; 34:306-313.
17. Hadziyannis SJ, Papatheodoridis GV, Vassilopoulos D: Medscape General Medicine 2003; http://www.medscape.com/viewarticle/459763.
18. Kramvis A, Bukofzer S, Kew MC, Song E: Nucleic acid sequence analysis of the precore region of hepatitis B virus from sera of Southern African black adult carriers of the virus. Hepatology 1997; 25:235-240.
19. Akarca US, Greene S, Lok ASF: Detection of precore hepatitis B virus mutants in asymptomatic HbsAg-positive family members. Hepatology 1994; 19:1366-1370.
20. Karasawa T, Aizawa Y, Zeniya M, Kuramoto A, Shirasawa T, Toda G: Genetic heterogeneity in the precore region of hepatitis B virus in hepatitis B e antigen-negative chronic hepatitis B patients: Spontaneous seroconversion and interferon-induced seroconversion. J Med Virol 1995; 45:373-380.
21. Chun YK, Kim JY, Woo HJ, Oh SM, Kang I, Ha J, Kim SS: No significant correlation exists between core promoter mutations, viral replication, and liver damage in chronic hepatitis B infection. Hepatology 2000; 32:1154-1162.
22. Lin C-L, Liao L-Y, Chen P-J, Lai M-Y, Chen D-S, Kao J-H: Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy. Liver Internat 2004; 24:9-15.
23. Chen WN, Oon CJ: Mutations and deletions in core promoter and precore stop codon in relation to viral replication and liver damage in Singaporean hepatitis B virus carriers. Eur J Clin Invest 2000; 30:787-792.
24. Yotsuyanagi H, Hino K, Tomita E, Toyoda J, Yasuda K, Lino S: Precore and core promoter mutations, hepatitis B virus DNA levels and progressive liver injury in chronic hepatitis B. J Hepatol 2002; 37:355-363.
25. Kao J-H, Wu N-H, Chen P-J, Lai M-Y, Chen D-S: Hepatitis B genotypes and the response to interferon therapy. J Hepatol 2000; 33:998-1002.
26. Tacke F, Gehrke C, Luedde T, Heim A, Manns MP, Trautwein C: Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of lamivudine-resistant mutants. J Virol 2004; 78:8524-8535.